Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer

Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences